Improved glycemic outcomes in people with type 2 diabetes using smart blood glucose monitoring integrated with popular digital health therapeutics.

For all 68 subjects, mean BG reduced by − 21.8 mg/dL (171.8 to 150.0 mg/dL, 95% CI, − 36.6 to − 7.0), readings in tight range (RITR) improved by + 13.7% points (%pts, 95% CI, 2.9 to 24.4) from 30.8 to 44.4% and readings in range (RIR) increased by + 7.2%pts from 66.8 to 74.0% but did not reach statistical significance (Figs. 3 , 4 , 5 and 6 ).

also in 111,027 other papers